Brian W Read

US Patent:

8301238, Oct 30, 2012

Filed:

Sep 30, 2011

Appl. No.:

13/250031

Inventors:

Zita S. Netzel - Los Altos CA, US
John Lemke - Pleasanton CA, US
David Seward - Seattle WA, US
Brian W. Read - Brier WA, US
Bradley E. White - Mason OH, US
Corinna X. Chen - Oakland CA, US
Paul Hayter - Mountain View CA, US

Assignee:

Incline Therapeutics, Inc. - Redwood City CA
Alza Corporation - Vacaville CA

International Classification:

A61N 1/30

US Classification:

604 20

Abstract:

A switch operated therapeutic agent delivery device is described. The device comprises two parts, which are assembled by a user prior to use. A first part contains a power supply and circuitry for the device; and a second part comprises electrodes and reservoirs containing the therapeutic agent to be delivered. The action of combining the two parts of the device causes the two parts to be irreversibly coupled together, completes an electrical connection between the two parts, and closes one or more switches, thereby connecting a power source, such as a battery, into the device's circuitry, thereby powering the device on so that it is ready for use. The device can then be attached to a patient, who can operate the device by pressing a button in a proper sequence.

US Patent:

8428708, Apr 23, 2013

Filed:

May 21, 2012

Appl. No.:

13/476960

Inventors:

Bradley E. White - Mason OH, US
John Lemke - Pleasanton CA, US
Paul Hayter - Mountain View CA, US
Corinna X. Chen - Oakland CA, US
Brian W. Read - Brier WA, US
Jason E. Dougherty - Seattle WA, US

Assignee:

Incline Therapeutics, Inc. - Redwood City CA
Alza Corporation - Vacaville CA

International Classification:

A61N 1/30

US Classification:

604 20, 604501

Abstract:

Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e. g. , which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

US Patent:

8428709, Apr 23, 2013

Filed:

Jun 11, 2012

Appl. No.:

13/493314

Inventors:

Bradley E. White - Mason OH, US
Paul Hayter - Mountain View CA, US
John Lemke - Pleasanton CA, US
Scot Satre - Brentwood CA, US
Corinna X. Chen - Oakland CA, US
Brian W. Read - Brier WA, US
Jason E. Dougherty - Seattle WA, US

Assignee:

Incline Therapeutics, Inc. - Redwood City CA
Alza Corporation - Vacaville CA

International Classification:

A61N 1/30

US Classification:

604 20, 604 21, 604500, 604501, 607 62, 607 63, 607 64, 323265, 323283, 323284, 323285, 323286, 323287, 323288, 323289, 323290

Abstract:

Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e. g. , anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e. g. , cathode).

US Patent:

20120253262, Oct 4, 2012

Filed:

Sep 30, 2011

Appl. No.:

13/249975

Inventors:

John Lemke - Pleasanton CA, US
Scot Satre - Brentwood CA, US
Corinna X. Chen - Oakland CA, US
Brian W. Read - Brier WA, US

International Classification:

A61N 1/30
G01R 31/02

US Classification:

604 20, 324537

Abstract:

A switch operated therapeutic agent delivery device is described. Embodiments of the operated therapeutic agent delivery device include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, and a switch integrity subcircuit which is used to detect a fault or a precursor to a fault.

US Patent:

20130310729, Nov 21, 2013

Filed:

Apr 19, 2013

Appl. No.:

13/866371

Inventors:

Bradley E. WHITE - Mason OH, US
John LEMKE - Pleasanton CA, US
Paul HAYTER - Mountain View CA, US
Corinna X. CHEN - Oakland CA, US
Brian W. READ - Brier WA, US
Jason E. DOUGHERTY - Seattle WA, US

International Classification:

A61N 1/18

US Classification:

604 20

Abstract:

Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

US Patent:

20170341830, Nov 30, 2017

Filed:

May 25, 2017

Appl. No.:

15/605727

Inventors:

- Seattle WA, US
Brian W. Read - Brier WA, US
John M. Havard - Seattle WA, US
Christopher B. Harrison - Vashon WA, US
Paul H. Wierenga - Seattle WA, US

International Classification:

B65D 51/24
G01F 23/296
G01S 7/536
G01S 15/32

Abstract:

A method and beverage container assembly for determining a level of liquid in a beverage container having a lid removably attached thereto. The beverage container assembly including a sensor configured to measure sound waves in the beverage container assembly. A processor is electronically coupled to the sensor, and to memory provided with executable instructions for causing the processor to determine the level of liquid. The executable instructions, when executed by the processor, cause the processor to receive a sound wave measurement from the sensor, obtain a frequency characteristic of the sound wave measurement, and obtain reference information regarding a set of characteristics of the beverage container assembly. The processor may determine the level of liquid in the beverage container assembly based on the frequency characteristic and the reference information.

US Patent:

20170239468, Aug 24, 2017

Filed:

May 8, 2017

Appl. No.:

15/589754

Inventors:

John LEMKE - Pleasanton CA, US
Scot SATRE - Brentwood CA, US
Corinna X. CHEN - Oakland CA, US
Brian W. READ - Brier WA, US
Zita S. NETZEL - Los Altos CA, US
David SEWARD - Seattle WA, US
Bradley E. WHITE - Lebanon OH, US
Paul HAYTER - Mountain View CA, US
Jason E. DOUGHERTY - Seattle WA, US

International Classification:

A61N 1/32
A61K 31/4468
B29C 65/48
B29C 65/56
A61N 1/08
A61M 37/00

Abstract:

A switch-operated therapeutic agent delivery device. Embodiments of the operated therapeutic agent delivery device my include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test. The switch operated therapeutic agent delivery device may have two parts, which are assembled by a user prior to use. These devices may be configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices may indirectly control and/or monitor the applied current without directly measuring from the cathode of the patient terminal.

US Patent:

20160296750, Oct 13, 2016

Filed:

Jun 13, 2016

Appl. No.:

15/181166

Inventors:

Zita S. NETZEL - Los Altos CA, US
John LEMKE - Pleasanton CA, US
David SEWARD - Seattle WA, US
Brian W. READ - Brier WA, US
Bradley E. WHITE - Lebannon OH, US
Corinna X. CHEN - Oakland CA, US
Paul HAYTER - Mountain View CA, US

International Classification:

A61N 1/08
A61N 1/32
A61N 1/04

Abstract:

A switch operated therapeutic agent delivery device is described. The device comprises two parts, which are assembled by a user prior to use. A first part contains a power supply and circuitry for the device; and a second part comprises electrodes and reservoirs containing the therapeutic agent to be delivered. The action of combining the two parts of the device causes the two parts to be irreversibly coupled together, completes an electrical connection between the two parts, and closes one or more switches, thereby connecting a power source, such as a battery, into the device's circuitry, thereby powering the device on so that it is ready for use. The device can then be attached to a patient, who can operate the device by pressing a button in a proper sequence.